Literature DB >> 12838037

The effect of amphetamine on Kamin blocking and overshadowing.

C M P O'Tuathaigh1, C Salum, A M J Young, A D Pickering, M H Joseph, P M Moran.   

Abstract

Schizophrenic patients show deficits on stimulus salience tasks such as latent inhibition and blocking, which measure the ability to disregard irrelevant stimuli. Amphetamine-treated animals show similar deficits in analogous tasks, thereby providing a model of the stimulus-selection deficits observed in schizophrenia. In two experiments, the effect of the indirect dopamine (DA) agonist D-amphetamine sulphate (1.0 mg/kg, i.p.) on Kamin blocking and overshadowing were examined and compared, in the rat, using the conditioned lick suppression procedure. The aim was to provide some insight into the behavioural and pharmacological mechanisms underlying amphetamine effects in both paradigms. In experiment 1, it was shown that amphetamine selectively disrupted Kamin blocking, when given either at stage 2 alone, or at both stages of the task. In experiment 2, amphetamine treatment significantly abolished Kamin blocking and overshadowing, when administered prior to compound conditioning in both tasks. These data suggest that dopamine may play a critical role in mediating performance in tasks measuring stimulus salience processes. The results are discussed in the framework of the role of DA in stimulus-selection performance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838037     DOI: 10.1097/01.fbp.0000080416.18561.3e

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  14 in total

1.  Blocking of conditioning to a cocaine-paired stimulus: testing the hypothesis that cocaine perpetually produces a signal of larger-than-expected reward.

Authors:  Leigh V Panlilio; Eric B Thorndike; Charles W Schindler
Journal:  Pharmacol Biochem Behav       Date:  2007-03-15       Impact factor: 3.533

2.  Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.

Authors:  Tilly Chang; Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

Review 3.  Explaining Delusions: Reducing Uncertainty Through Basic and Computational Neuroscience.

Authors:  Erin J Feeney; Stephanie M Groman; Jane R Taylor; Philip R Corlett
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

4.  Opioid regulation of Pavlovian overshadowing in fear conditioning.

Authors:  Moriel Zelikowsky; Michael S Fanselow
Journal:  Behav Neurosci       Date:  2010-08       Impact factor: 1.912

5.  Amphetamine selectively enhances avoidance responding to a less salient stimulus in rats.

Authors:  Ming Li; Wei He; Rebecca Munro
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

6.  Kamin blocking is associated with reduced medial-frontal gyrus activation: implications for prediction error abnormality in schizophrenia.

Authors:  Paula M Moran; Jennifer L Rouse; Benjamin Cross; Rhiannon Corcoran; Martin Schürmann
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

7.  Dopamine D1 receptor involvement in latent inhibition and overshadowing.

Authors:  Andrew J D Nelson; Karen E Thur; Helen J Cassaday
Journal:  Int J Neuropsychopharmacol       Date:  2011-12-16       Impact factor: 5.176

8.  Cognition-emotion dysinteraction in schizophrenia.

Authors:  Alan Anticevic; Philip R Corlett
Journal:  Front Psychol       Date:  2012-10-12

9.  The computational anatomy of psychosis.

Authors:  Rick A Adams; Klaas Enno Stephan; Harriet R Brown; Christopher D Frith; Karl J Friston
Journal:  Front Psychiatry       Date:  2013-05-30       Impact factor: 4.157

10.  Ketamine effects on memory reconsolidation favor a learning model of delusions.

Authors:  Philip R Corlett; Victoria Cambridge; Jennifer M Gardner; Jennifer S Piggot; Danielle C Turner; Jessica C Everitt; Fernando Sergio Arana; Hannah L Morgan; Amy L Milton; Jonathan L Lee; Michael R F Aitken; Anthony Dickinson; Barry J Everitt; Anthony R Absalom; Ram Adapa; Naresh Subramanian; Jane R Taylor; John H Krystal; Paul C Fletcher
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.